肠促胰岛素相关药物的不良反应(4)
[18] Williams-Herman D, Engel SS, Round E, et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes [EB/OL]. [2012-01-24]. http://www.biomedcentral.com/content/pdf/1472-6823-10-7.pdf.[19] Cheng V, Kashyap SR. Weight considerations in pharmacotherapy for type 2 diabetes [EB/OL]. [2012-01-24]. http://www.hindawi.com/journals/jobes/2011/984245/.
[20] Ligueros-Saylan M ......
您现在查看是摘要页,全文长 2623 字符。